Literature DB >> 23329759

Hyperprolactinemia in children: clinical features and long-term results.

Gonul Catli1, Ayhan Abaci, Ayca Altincik, Korcan Demir, Sule Can, Atilla Buyukgebiz, Ece Bober.   

Abstract

Hyperprolactinemia is a rare endocrine disorder in childhood, which may result from hypophyseal adenoma. We aimed to review the etiologic reasons and clinical features in hyperprolactinemia patients retrospectively. The mean age of 11 female patients at diagnosis was 14.2 ± 1.3 years. Five patients had microadenoma, four patients had macroadenoma, and two patients were diagnosed with idiopathic hyperprolactinemia. The most frequent symptoms were menstrual disorders, headache, and galactorrhea, and one-third of the patients had obesity at diagnosis. There was no anterior pituitary hormone deficiency. All patients received bromocriptine as initial therapy; only two patients with macroadenoma and one patient with microadenoma were switched to cabergoline. Transsphenoidal surgery was performed for a patient with macroadenoma, who had cavernous sinus invasion and visual field defect. Medical treatment should be the first-line treatment option in both microadenoma and macroadenoma cases without any neurological signs. Surgery should be employed with limited indications.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23329759     DOI: 10.1515/jpem-2012-0130

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  6 in total

1.  A middle cerebral artery ischemic stroke occurring in a child with a large prolactinoma.

Authors:  Taemin Oh; Dominic Amara; Nalin Gupta; Patricia Clerkin
Journal:  Childs Nerv Syst       Date:  2019-12-18       Impact factor: 1.475

Review 2.  Prolactinoma through the female life cycle.

Authors:  Deirdre Cocks Eschler; Pedram Javanmard; Katherine Cox; Eliza B Geer
Journal:  Endocrine       Date:  2017-11-24       Impact factor: 3.633

3.  Pediatric prolactinoma: initial presentation, treatment, and long-term prognosis.

Authors:  Anika Hoffmann; Sarah Adelmann; Kristin Lohle; Alexander Claviez; Hermann L Müller
Journal:  Eur J Pediatr       Date:  2017-11-22       Impact factor: 3.183

4.  Bromocriptine as a Novel Pharmacological Chaperone for Mucopolysaccharidosis IV A.

Authors:  Sergio Olarte-Avellaneda; Jacobo Cepeda Del Castillo; Andrés Felipe Rojas-Rodriguez; Oscar Sánchez; Alexander Rodríguez-López; Diego A Suárez García; Luz Mary Salazar Pulido; Carlos J Alméciga-Díaz
Journal:  ACS Med Chem Lett       Date:  2020-06-24       Impact factor: 4.345

5.  Long-term cardiometabolic outcome in patients with pituitary adenoma diagnosed in chilhood and adolescence.

Authors:  Salvatore Giovinazzo; Soraya Puglisi; Oana R Cotta; Angela Alibrandi; Tommaso Aversa; Laura Cannavò; Francesco Ferraù; Salvatore Cannavò
Journal:  Pituitary       Date:  2021-01-19       Impact factor: 4.107

6.  Hyperprolactinemia in Children with Subclinical Hypothyroidism.

Authors:  Neera Sharma; Deep Dutta; Lokesh Kumar Sharma
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-05-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.